ELI LILLY AND COMPAN

LLY
Delayed Quote. Delayed  - 01/15 04:10:00 pm
190.77USD +2.19%

Turn to zoom
Prev.186.6900
Open186.8000
High191.7800
Low186.8000
Volume4 413 184
Latest news
17h ago
17h ago
3d ago
3d ago
Chart ELI LILLY AND COMPANY
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance206214196
Spread/Res.-7,3%-11%-2,7%
Spread/Supp.21%21%24%
Support158158154
Financials
Sales 2020 24 408 M - -
Net income 2020 5 802 M - -
Net Debt 2020 11 301 M - -
P/E ratio 2020 30,0x
Yield 2020 1,56%
Capitalization 173 B 173 B -
EV / Sales 2020 7,55x
EV / Sales 2021 6,63x
Nbr of Employees 33 625
Free-Float 99,8%
Company
Eli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company's human pharmaceutical business segment sells medicines, which are discovered or...

>> Read more
Sector :
Pharmaceuticals - NEC
Calendar :
2021-01-29 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 181,58 $
Last Close Price 190,77 $
Spread / Highest target 19,0%
Spread / Average Target -4,82%
Spread / Lowest Target -37,1%